4.5 Review

A Multiscale View of the Mechanisms Underlying Ketamine's Antidepressant Effects: An Update on Neuronal Calcium Signaling

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Yan Wei et al.

Summary: The discovery of antidepressant actions of (R,S)-ketamine has been a crucial breakthrough in mood disorder research. Esketamine nasal spray has been approved for treatment-resistant depression, but arketamine has shown greater potency and longer-lasting effects in rodents. Clinical trials have not replicated the robust antidepressant actions of ketamine-related compounds seen in rodents in human patients, highlighting the complexity of psychiatric disorders.

MOLECULAR PSYCHIATRY (2022)

Review Neurosciences

Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities

Ryota Shinohara et al.

Summary: The discovery of the rapid-acting antidepressant effects of ketamine has revolutionized our approach to treating severe depression, while also presenting new challenges. It is increasingly crucial to focus on the downstream molecular mechanisms of ketamine and its effects on the brain circuitry and networks.

BIOLOGICAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Antidepressant drugs act by directly binding to TRKB neurotrophin receptors

Plinio C. Casarotto et al.

Summary: The study reveals that antidepressant drugs bind directly to the TRKB receptor, facilitating its activation at the synapse and potentially explaining the mechanism behind antidepressant action.
Review Pharmacology & Pharmacy

Targeting the dysfunction of glutamate receptors for the development of novel antidepressants

Cong-Yuan Xia et al.

Summary: This review discusses the relationships between glutamate receptor subunits and depressive-like behaviors, summarizing the alterations of these subunits in patients with MDD and animal models of depression, as well as surveying animal behaviors in response to dysfunction of glutamate receptor subunits.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications

Jaclyn N. Highland et al.

Summary: HNKs are metabolites of ketamine that have potential antidepressant and other physiological effects, with a focus on the antidepressant actions and mechanisms of (2R,6R)-HNK.

PHARMACOLOGICAL REVIEWS (2021)

Review Neurosciences

Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action

Eero Castren et al.

Summary: Neurotrophic factors, especially BDNF, are associated with depression and the action of antidepressant drugs, with impaired BDNF signaling linked to mood disorders. Increased BDNF expression and signaling have been linked to the mechanisms of antidepressant drugs, and BDNF regulates various types of neuronal plasticities in the brain, which are connected to antidepressant action. The hypothesis of a connection between neurotrophic factors and neuronal plasticity with mood disorders and antidepressant action has been further supported by recent evidence.

BIOLOGICAL PSYCHIATRY (2021)

Article Multidisciplinary Sciences

Gene-environment interactions mediate stress susceptibility and resilience through the CaMKIIβ/TARPγ-8/AMPAR pathway

Yusuke Sakai et al.

Summary: The study explores the role of CaMKII beta in the ventral hippocampus in depression susceptibility and resilience, revealing that its modulation of TARP gamma-8 phosphorylation enhances stress resilience by increasing the expression of AMPA receptor subunit GluA1. These findings provide new insights into the molecular mechanisms underlying chronic stress-induced behavioral changes and offer strategies for preventing and treating stress-related psychiatric disorders.

ISCIENCE (2021)

Article Neurosciences

Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation

Ji-Woon Kim et al.

Summary: This study shows that MeCP2 phosphorylation at a specific site downstream of BDNF is essential for the sustained antidepressant effects of ketamine and scopolamine, and plays a critical role in long-term regulation of synaptic strength. These findings highlight the importance of MeCP2 and associated synaptic plasticity in mediating sustained antidepressant effects of ketamine and scopolamine.

NATURE NEUROSCIENCE (2021)

Review Neurosciences

The Molecular Basis of Depression: Implications of Sex-Related Differences in Epigenetic Regulation

Ayako Kawatake-Kuno et al.

Summary: Major depressive disorder (MDD) is a leading cause of disability worldwide, with aberrant neuroplasticity mediated by epigenetic dysregulation playing a crucial role in its development. Sex-related differences in the pathophysiology of MDD and response to antidepressants have also been observed. Research suggests that sex-dependent epigenetic alterations may influence susceptibility to stress and depression.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Behavioral Sciences

Ketamine: The final frontier or another depressing end?

Omar K. Sial et al.

BEHAVIOURAL BRAIN RESEARCH (2020)

Review Neurosciences

Circuits and functions of the lateral habenula in health and in disease

Hailan Hu et al.

NATURE REVIEWS NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Epigenetic marks and their relationship with BDNF in the brain of suicide victims

Paulina Misztak et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

Antidepressant actions of ketamine engage cell-specific translation via eIF4E

Argel Aguilar-Valles et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function

Ronald S. Duman et al.

MOLECULAR PSYCHIATRY (2019)

Editorial Material Neurosciences

Ketamine: A Paradigm Shift for Depression Research and Treatment

John H. Krystal et al.

NEURON (2019)

Article Multidisciplinary Sciences

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

Eric W. Lumsden et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Neurosciences

Multiscale Neuroscience of Psychiatric Disorders

Martijn P. van den Heuvel et al.

BIOLOGICAL PSYCHIATRY (2019)

Review Clinical Neurology

Epigenetic mechanisms of major depression: Targeting neuronal plasticity

Shusaku Uchida et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)

Article Neurosciences

Opposite Molecular Signatures of Depression in Men and Women

Marianne L. Seney et al.

BIOLOGICAL PSYCHIATRY (2018)

Review Neurosciences

Epigenetic regulation of Fgf1 transcription by CRTC1 and memory enhancement

Shusaku Uchida et al.

BRAIN RESEARCH BULLETIN (2018)

Article Clinical Neurology

Association of BDNF Va166Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide

Mariam M. Youssef et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Neurosciences

(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice

Jun-ichi Yamaguchi et al.

NEUROPSYCHOPHARMACOLOGY (2018)

Review Neurosciences

Synaptically Localized Transcriptional Regulators in Memory Formation

Shusaku Uchida et al.

NEUROSCIENCE (2018)

Article Multidisciplinary Sciences

Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression

Yihui Cui et al.

NATURE (2018)

Article Multidisciplinary Sciences

Ketamine blocks bursting in the lateral habenula to rapidly relieve depression

Yan Yang et al.

NATURE (2018)

Article Neurosciences

Ketamine Treatment and Global Brain Connectivity in Major Depression

Chadi G. Abdallah et al.

NEUROPSYCHOPHARMACOLOGY (2017)

Review Biochemistry & Molecular Biology

Calmodulin kinases: essential regulators in health and disease

Sayaka Takemoto-Kimura et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Article Pharmacology & Pharmacy

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine

Kenichi Fukumoto et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Letter Multidisciplinary Sciences

Effects of a ketamine metabolite on synaptic NMDAR function

Kanzo Suzuki et al.

NATURE (2017)

Article Psychiatry

Schizophrenia and depression, two poles of endocannabinoid system deregulation

Maria Rodriguez-Munoz et al.

TRANSLATIONAL PSYCHIATRY (2017)

Review Neurosciences

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants

Shigeyuki Chaki

CURRENT NEUROPHARMACOLOGY (2017)

Article Neurosciences

Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior

Naoko Abe-Higuchi et al.

BIOLOGICAL PSYCHIATRY (2016)

Article Neurosciences

Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice

Fumihiro Higuchi et al.

JOURNAL OF NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos et al.

NATURE (2016)

Article Clinical Neurology

Epigenetic Basis of Mental Illness

Eric J. Nestler et al.

NEUROSCIENTIST (2016)

Review Medicine, Legal

Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability

R. Giorgetti et al.

FORENSIC SCIENCE INTERNATIONAL (2015)

Article Multidisciplinary Sciences

Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats

Miyeon Choi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Neurosciences

An excitatory synapse hypothesis of depression

Scott M. Thompson et al.

TRENDS IN NEUROSCIENCES (2015)

Article Clinical Neurology

BDNF Release Is Required for the Behavioral Actions of Ketamine

Ashley E. Lepack et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)

Article Neurosciences

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

Elena Nosyreva et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)

Article Psychology, Clinical

Effects of chronic ketamine use on frontal and medial temporal cognition

Kahlen W. S. Chan et al.

ADDICTIVE BEHAVIORS (2013)

Review Neurosciences

Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond

John H. Krystal et al.

BIOLOGICAL PSYCHIATRY (2013)

Article Neurosciences

Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation

Elena Nosyreva et al.

JOURNAL OF NEUROSCIENCE (2013)

Review Neurosciences

Histone acetylation: molecular mnemonics on the chromatin

Johannes Graeff et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Review Neurosciences

AMPARs and Synaptic Plasticity: The Last 25 Years

Richard L. Huganir et al.

NEURON (2013)

Article Multidisciplinary Sciences

βCaMKII in Lateral Habenula Mediates Core Symptoms of Depression

Kun Li et al.

SCIENCE (2013)

Article Biochemistry & Molecular Biology

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder

Hyo Jung Kang et al.

NATURE MEDICINE (2012)

Review Neurosciences

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

Maurizio Popoli et al.

NATURE REVIEWS NEUROSCIENCE (2012)

Review Multidisciplinary Sciences

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

Ronald S. Duman et al.

SCIENCE (2012)

Article Multidisciplinary Sciences

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Anita E. Autry et al.

NATURE (2011)

Article Neurosciences

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

Marije aan het Rot et al.

BIOLOGICAL PSYCHIATRY (2010)

Article Psychiatry

Altered gene expression of histone deacetylases in mood disorder patients

Teruyuki Hobara et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2010)

Review Neurosciences

Neurocircuitry of Mood Disorders

Joseph L. Price et al.

NEUROPSYCHOPHARMACOLOGY (2010)

Review Neurosciences

TrkB signalling pathways in LTP and learning

Liliana Minichiello

NATURE REVIEWS NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

The molecular neurobiology of depression

Vaishnav Krishnan et al.

NATURE (2008)

Review Clinical Neurology

Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression

Jun-ichi Iga et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Review Neurosciences

A neurotrophic model for stress-related mood disorders

Ronald S. Duman et al.

BIOLOGICAL PSYCHIATRY (2006)

Review Neurosciences

New approaches to antidepressant drug discovery: beyond monoamines

O Berton et al.

NATURE REVIEWS NEUROSCIENCE (2006)

Article Neurosciences

NMDA receptor-mediated control of protein synthesis at developing synapses

AJ Scheetz et al.

NATURE NEUROSCIENCE (2000)